Johnson & Johnson
It's been a challenging year for Johnson & Johnson (JNJ) -- even though shares of the healthcare product behemoth has seen its shares climb 7.7% since the start of 2012, the S&P has climbed almost twice as much. And now, JNJ could be getting ready to erase some of its already-trailing gains thanks to a double top pattern that's shaping up in shares.
The double top is a pattern that's formed by two swing highs that top out at approximately the same price level. They're separated by a trough, a level that marks the trigger point for this trade. For Johnson & Johnson, that level comes in just above $68; if shares slip below that price, then this trade has triggered, and it's time to be a near-term seller (or a short it). If you're wondering about this pattern's efficacy, just take another look at the AT&T chart we already saw: it was a double top back in October that sent T into the downtrend it's just now recovering from.
When you're looking at any technical setups, it's important to think of them in terms of buyers and sellers. For JNJ, those two tops stalled out at a price where sellers became much more eager to sell shares and take gains than buyers were to buy. And while buyers were wiling to step in and halt the decline just above our $68 level, a print below that line means that increasingly anxious sellers have overpowered them.This isn't a long-term downside setup for JNJ, but the trading implications are big enough to warrant keeping a close eye on this stock. That's especially true if you're thinking about planning an exit for tax purposes before year-end.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV